Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
+3.08M
-
Total reported value, excl. options
-
$52.5M
-
Value change
-
+$13.2M
-
Number of buys
-
21
-
Number of sells
-
-11
-
Price
-
$4.21
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q3 2023
48 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q3 2023.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
of 51.9M outstanding shares and own 24.04% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.25M shares), Nantahala Capital Management, LLC (2.3M shares), Point72 Asset Management, L.P. (1.18M shares), AIGH Capital Management LLC (1.14M shares), MILLENNIUM MANAGEMENT LLC (994K shares), VANGUARD GROUP INC (753K shares), J. Goldman & Co LP (495K shares), CITIGROUP INC (450K shares), BARCLAYS PLC (371K shares), and Worth Venture Partners, LLC (281K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.